Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ectoin is a naturally occurring extremolyte, a small organic molecule produced by halophilic bacteria to survive extreme environmental conditions. In topical emollient formulations, ectoin acts as a compatible solute that binds water molecules to create a stable, protective hydration shell (the Ectoin Hydro Complex) around proteins and lipid bilayers. This physical mechanism stabilizes the skin barrier, reduces transepidermal water loss (TEWL), and protects cells from environmental stressors and allergens. It is used as a non-steroidal treatment for inflammatory skin conditions such as atopic dermatitis, eczema, and psoriasis, providing anti-inflammatory effects and symptom relief (redness, pruritus) comparable to mild corticosteroids in some studies. Ectoin-containing emollients are often classified as medical devices in the European Union.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ectoin (bitop AG).